Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MRNA | Moderna, Inc. | 2.11% | 155.96 | 0.0% | $3291.50m | |
| BIIB | Biogen, Inc. | 0.67% | 241.77 | 1.7% | $680.21m | |
| NVAX | Novavax, Inc. | -9.40% | 126.39 | 92.9% | $607.79m | |
| AMGN | Amgen, Inc. | 1.00% | 224.26 | 1.3% | $579.46m | |
| BNTX | BioNTech SE | -4.73% | 118.36 | 0.0% | $579.03m | |
| GILD | Gilead Sciences, Inc. | 1.85% | 61.79 | 1.0% | $530.54m | |
| VRTX | Vertex Pharmaceuticals, Inc. | 0.75% | 229.46 | 1.9% | $503.61m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 1.50% | 523.78 | 2.7% | $497.28m | |
| ILMN | Illumina, Inc. | 4.02% | 335.05 | 3.5% | $392.30m | |
| APVO | Aptevo Therapeutics, Inc. | 0.62% | 44.00 | 18.3% | $243.82m | |
| SGEN | Seagen Inc. | 4.13% | 177.35 | 5.8% | $183.23m | |
| EXAS | EXACT Sciences Corp. | 3.74% | 125.58 | 19.6% | $179.60m | |
| ALXN | Alexion Pharmaceuticals, Inc. | -0.58% | 121.40 | 2.0% | $148.56m | |
| HALO | Halozyme Therapeutics, Inc. | 2.48% | 40.07 | 18.4% | $137.37m | |
| SRNE | Sorrento Therapeutics, Inc. | -2.32% | 8.01 | 1.4% | $136.55m |
Company Profile
Actinium Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. It is focused on developing Antibody Radiation-Conjugates, which combine the targeting ability of antibodies with the cell killing ability of radiation. The firm provides its service through Iomab-B, which is studied in the ongoing pivotal Phase 3 Study of Iomab-B in Elderly Relapsed or Refractory Acute Myeloid Leukemia (SIERRA) trial for BMT conditioning. The company was founded in 2002 and is headquartered in New York, NY.